2
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Completed
13
Active not recruiting
7
Unknown
3
Recruiting
3
Withdrawn
1
Terminated
1
Sponsor Class
OTHER
3
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Genitourinary
3
Conditions
Prostatic Neoplasms
2
Castration-resistant Prostate Cancer
1
Interventions
Cisplatin
517
Radiotherapy
378
Cyclophosphamide
368
Carboplatin
359
Capecitabine
342
Paclitaxel
337
Oxaliplatin
336
Gemcitabine
322
Docetaxel
317
Fluorouracil
290
Drug Therapy
276
Bevacizumab
248
apatinib
247
camrelizumab
219
Etoposide
201
Irinotecan
182
Doxorubicin
181
Leucovorin
163
Dexamethasone
161
pembrolizumab
153
Neoadjuvant Therapy
146
sintilimab
145
anlotinib
140
Blood Specimen Collection
140
Pemetrexed
138
Cytarabine
138
toripalimab
133
Surgical Procedures, Operative
131
Radiosurgery
131
S 1 (combination)
125
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Unknown
×
Radium-223
×
Clear all
NCT03432949
2024-01-24
TRANCE
University Health Network, Toronto
Phase 4
Unknown
24 enrolled
NCT03305224
2021-09-09
CORE-OCU
Osaka City University
Phase 2
Unknown
10 enrolled
NCT04110782
2019-10-01
RaProRad
Azienda Policlinico Umberto I
Unknown
400 enrolled